Douglas Kell

Douglas Kell

dbkell.bsky.social

Research Scientist who prefers facts to lies. Focus on Long COVID. Free book: http://osf.io/pnxcs/.

👤 Joined on 04 October 2023

1764

Followers

1946

Following

149

Total Posts

📜 Kullanıcı Geçmişi

  • 04 Eki 2023, 19:51
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @dbkell.bsky.social
  • 10 Kas 2023, 01:42
    🔄 Profil bilgileri güncellendi

❤️ Beğendiği Gönderiler

From my wonderful Colleagues Team Clots... @resiapretorius.bsky.social @dbkell.bsky.social 😇🙏🏻 doi.org/10.1038/s414...

Show Post
Carl
14 August 2026 10:26

@dbkell.bsky.social and team have to their immense credit taken it seriously from the early days. www.frontiersin.org/journals/cel...

Show Post
Analyst
19 July 2026 15:37

In the latest issue of ‪Analyst: Rapid antimicrobial susceptibility testing in bloodstream infections: current landscape and emerging technologies. #OpenAccess from Douglas B. Kell et al @dbkell.bsky.social @livuni-ismib.bsky.social Read now: pubs.rsc.org/an/article/d...

Show Post
Alan Rew
16 June 2026 17:05

A couple of BlueSky accounts doing research on specific Long COVID effects (microclots) you might be interested in following @dbkell.bsky.social @resiapretorius.bsky.social

Show Post

Celebrating 120 years of the Biochemical Journal, we're hosting a special free webinar on 17 June where @dbkell.bsky.social will be exploring how fibrinaloid microclots affect the microcirculation, and the effects on chronic inflammatory diseases. Register now 🧪 bit.ly/3S1m6pC

Show Post

Select language

Install App

Install App